Stay updated on STORM Clinical Trial - Selinexor in Refractory Myeloma
Sign up to get notified when there's something new on the STORM Clinical Trial - Selinexor in Refractory Myeloma page.

Latest updates to the STORM Clinical Trial - Selinexor in Refractory Myeloma page
- Check6 days agoChange DetectedShow glossary and color-coded change indicators (green for additions, red for deletions) were added to the history view, along with a new revision note (Revision: v3.4.0). The previous No FEAR Act data entry and Revision: v3.3.4 were removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the Record History page for NCT02336815; this is a minor version update with no changes to study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedA new revision entry 'Revision: v3.3.3' was added to the study record history; the footer now removes 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check77 days agoChange DetectedRemoved the site-wide funding-status banner about government delays. This banner did not affect the study data or the history of this trial record.SummaryDifference0.4%

- Check92 days agoChange DetectedThe screenshots show updates to the record history (additional version entries and status notes) rather than substantive changes to core study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to STORM Clinical Trial - Selinexor in Refractory Myeloma
Enter your email address, and we'll notify you when there's something new on the STORM Clinical Trial - Selinexor in Refractory Myeloma page.